Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000435694

Medchemexpress LLC L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(1S)-2-carboxy-1-formyleth | 244133-31-1 | 98.9% | 480.94 | 10 MG
SDP

Catalog No. 5000435694
Encompass_Preferred

VRT-043198, the agent metabolite of VX-765 (Belnacasan), is a potent, selective, and blood-brain barrier permeable inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases. It exhibits Ki values of 0.8 nM for ICE/caspase-1 and 0.6 nM for caspase-4.

  • Potent, selective, and blood-brain barrier permeable inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.
  • Exhibits Ki values of 0.8 nM for ICE/caspase-1 and 0.6 nM for caspase-4.
  • Exhibits 100- to 10,000-fold selectivity against other caspases (caspase-3 and -6 to -9).
  • Inhibits the release of interleukin (IL)-1β and IL-18.
  • Little effect on the release of other cytokines, including IL-1α, tumor necrosis factor-, IL-6, and IL-8.
  • Inhibited IL-1β release from PBMCs (n = 8) and whole blood (n = 4) with IC50 values of 0.67±0.55 and 1.9±0.80 nM, respectively.
  • Lacks potent antiapoptotic activity.
  • For research use only.

Catalog No. 50-004-35694 Supplier Medchemexpress LLC Supplier No. HY11222610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

VRT-043198, the agent metabolite of VX-765 (Belnacasan), is a potent, selective, and blood-brain barrier permeable inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases. It exhibits Ki values of 0.8 nM for ICE/caspase-1 and 0.6 nM for caspase-4.

  • Potent, selective, and blood-brain barrier permeable inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases.
  • Exhibits Ki values of 0.8 nM for ICE/caspase-1 and 0.6 nM for caspase-4.
  • Exhibits 100- to 10,000-fold selectivity against other caspases (caspase-3 and -6 to -9).
  • Inhibits the release of interleukin (IL)-1β and IL-18.
  • Little effect on the release of other cytokines, including IL-1α, tumor necrosis factor-, IL-6, and IL-8.
  • Inhibited IL-1β release from PBMCs (n = 8) and whole blood (n = 4) with IC50 values of 0.67±0.55 and 1.9±0.80 nM, respectively.
  • Lacks potent antiapoptotic activity.
  • For research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.